A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
Primary
- To investigate the safety and tolerability of LCB01-0371 after a single oral dose
Secondary
- To investigate the pharmacokinetic characteristics of LCB01-0371 after a single oral
dose
- To investigate the safety of LCB01-0371 after a single oral dose